Principal Financial Group’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $71.5M | Sell |
1,675,210
-11,243
| -0.7% | -$611K | 0.04% | 398 |
|
|
2026
Q1 | $106M | Buy |
1,686,453
+14,795
| +0.9% | +$1.18M | 0.06% | 271 |
|
|
2025
Q4 | $159M | Buy |
1,671,658
+34,420
| +2% | +$3.37M | 0.08% | 213 |
|
|
2025
Q3 | $160M | Sell |
1,637,238
-215,555
| -12% | -$22.3M | 0.08% | 209 |
|
|
2025
Q2 | $199M | Sell |
1,852,793
-34,044
| -2% | -$3.44M | 0.11% | 187 |
|
|
2025
Q1 | $190M | Sell |
1,886,837
-106,607
| -5% | -$10.7M | 0.11% | 180 |
|
|
2024
Q4 | $178M | Sell |
1,993,444
-16,997
| -0.8% | -$1.5M | 0.1% | 189 |
|
|
2024
Q3 | $168M | Buy |
2,010,441
+111,724
| +6% | +$8.81M | 0.09% | 195 |
|
|
2024
Q2 | $146M | Sell |
1,898,717
-32,366
| -2% | -$2.37M | 0.09% | 194 |
|
|
2024
Q1 | $132M | Buy |
1,931,083
+47,480
| +3% | +$3.05M | 0.08% | 219 |
|
|
2023
Q4 | $109M | Buy |
1,883,603
+14,612
| +0.8% | +$780K | 0.07% | 234 |
|
|
2023
Q3 | $98.7M | Buy |
1,868,991
+38,249
| +2% | +$2.01M | 0.07% | 227 |
|
|
2023
Q2 | $99M | Sell |
1,830,742
-44,076
| -2% | -$2.3M | 0.07% | 248 |
|
|
2023
Q1 | $93.8M | Buy |
1,874,818
+259,015
| +16% | +$12.2M | 0.07% | 247 |
|
|
2022
Q4 | $74.8M | Sell |
1,615,803
-42,672
| -3% | -$1.85M | 0.06% | 287 |
|
|
2022
Q3 | $64.2M | Sell |
1,658,475
-30,523
| -2% | -$1.22M | 0.05% | 309 |
|
|
2022
Q2 | $62.9M | Buy |
1,688,998
+28,879
| +2% | +$1.18M | 0.05% | 329 |
|
|
2022
Q1 | $73.5M | Sell |
1,660,119
-14,648
| -0.9% | -$635K | 0.05% | 328 |
|
|
2021
Q4 | $71.1M | Sell |
1,674,767
-34,495
| -2% | -$1.45M | 0.04% | 341 |
|
|
2021
Q3 | $74.2M | Buy |
1,709,262
+888
| +0.1% | +$39.3K | 0.05% | 314 |
|
|
2021
Q2 | $73M | Buy |
1,708,374
+32,728
| +2% | +$1.38M | 0.05% | 329 |
|
|
2021
Q1 | $64.8M | Sell |
1,675,646
-319,573
| -16% | -$12.1M | 0.05% | 349 |
|
|
2020
Q4 | $71.7M | Buy |
1,995,219
+56,327
| +3% | +$2.03M | 0.05% | 312 |
|
|
2020
Q3 | $74.1M | Sell |
1,938,892
-101,607
| -5% | -$3.92M | 0.06% | 284 |
|
|
2020
Q2 | $71.6M | Buy |
2,040,499
+72,663
| +4% | +$2.62M | 0.06% | 290 |
|
|
2020
Q1 | $64.2M | Buy |
1,967,836
+1,560
| +0.1% | +$60.9K | 0.07% | 282 |
|
|
2019
Q4 | $88.9M | Sell |
1,966,276
-52,736
| -3% | -$2.21M | 0.07% | 288 |
|
|
2019
Q3 | $82.2M | Sell |
2,019,012
-7,735
| -0.4% | -$328K | 0.07% | 288 |
|
|
2019
Q2 | $87.1M | Buy |
2,026,747
+21,388
| +1% | +$823K | 0.08% | 280 |
|
|
2019
Q1 | $77M | Sell |
2,005,359
-10,647
| -0.5% | -$407K | 0.07% | 296 |
|
|
2018
Q4 | $71.2M | Sell |
2,016,006
-20,825
| -1% | -$755K | 0.08% | 285 |
|
|
2018
Q3 | $78.4M | Buy |
2,036,831
+29,761
| +1% | +$1.04M | 0.07% | 301 |
|
|
2018
Q2 | $65.6M | Buy |
2,007,070
+11,234
| +0.6% | +$339K | 0.06% | 334 |
|
|
2018
Q1 | $54.5M | Sell |
1,995,836
-11,375
| -0.6% | -$309K | 0.05% | 389 |
|
|
2017
Q4 | $49.8M | Buy |
2,007,211
+34,880
| +2% | +$962K | 0.05% | 415 |
|
|
2017
Q3 | $57.5M | Sell |
1,972,331
-59,280
| -3% | -$1.64M | 0.06% | 383 |
|
|
2017
Q2 | $56.3M | Buy |
2,031,611
+47,667
| +2% | +$1.27M | 0.06% | 378 |
|
|
2017
Q1 | $49.3M | Buy |
1,983,944
+33,763
| +2% | +$821K | 0.06% | 333 |
|
|
2016
Q4 | $42.2M | Sell |
1,950,181
-72,309
| -4% | -$1.58M | 0.05% | 360 |
|
|
2016
Q3 | $48.1M | Buy |
2,022,490
+75,925
| +4% | +$1.81M | 0.06% | 298 |
|
|
2016
Q2 | $45.5M | Sell |
1,946,565
-1,278
| -0.1% | -$27.6K | 0.06% | 290 |
|
|
2016
Q1 | $36.6M | Buy |
1,947,843
+42,435
| +2% | +$745K | 0.05% | 337 |
|
|
2015
Q4 | $35.1M | Buy |
1,905,408
+38,402
| +2% | +$688K | 0.05% | 343 |
|
|
2015
Q3 | $30.6M | Sell |
1,867,006
-6,961
| -0.4% | -$119K | 0.05% | 373 |
|
|
2015
Q2 | $33.2M | Buy |
1,873,967
+26,684
| +1% | +$477K | 0.05% | 371 |
|
|
2015
Q1 | $32.8M | Sell |
1,847,283
-14,635
| -0.8% | -$231K | 0.05% | 374 |
|
|
2014
Q4 | $24.7M | Sell |
1,861,918
-3,296,013
| -64% | -$42.1M | 0.04% | 450 |
|
|
2014
Q3 | $60.9M | Buy |
5,157,931
+3,288,714
| +176% | +$41.4M | 0.1% | 239 |
|
|
2014
Q2 | $23.9M | Buy |
1,869,217
+95,475
| +5% | +$1.24M | 0.04% | 441 |
|
|
2014
Q1 | $24M | Sell |
1,773,742
-168,567
| -9% | -$2.21M | 0.04% | 431 |
|
|
2013
Q4 | $23.3M | Buy |
1,942,309
+20,475
| +1% | +$242K | 0.04% | 441 |
|
|
2013
Q3 | $22.6M | Buy |
1,921,834
+292,346
| +18% | +$3.16M | 0.05% | 408 |
|
|
2013
Q2 | $15.1M | Buy |
+1,629,488
| New | +$13.8M | 0.03% | 551 |
|
Other funds holding BSX
Principal Financial Group's BSX Position: Q2 2026 in Review
Principal Financial Group reduced its Boston Scientific (BSX) stake by 0.67% in Q2 2026, selling an estimated $611K and leaving 1,675,210 shares worth $71.5M. The position accounts for 0.04% of the portfolio, ranked #398.
Principal Financial Group first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $199M in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Principal Financial Group held 1,675,210 shares of Boston Scientific worth $71.5M as of Q2 2026.
- Principal Financial Group sold 11,243 Boston Scientific shares in Q2 2026, an estimated $611K.
- Boston Scientific made up 0.04% of Principal Financial Group's portfolio in Q2 2026, its #398 holding.
- Principal Financial Group first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Principal Financial Group's Boston Scientific position peaked at $199M in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Principal Financial Group's 13F filing for Q2 2026, filed 4 Aug 2026.